[
    [
        {
            "time": "",
            "original_text": "净利一增一减，详解CRO龙头康龙化成和药明康德背后的差异化",
            "features": {
                "keywords": [
                    "净利",
                    "CRO",
                    "康龙化成",
                    "药明康德",
                    "差异化"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "净利一增一减，详解CRO龙头康龙化成和药明康德背后的差异化",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 3,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        }
    ]
]